Codiak BioSciences, Inc. (CDAK)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-03-30 | 2023-03-30 | S Sale |
See Remarks Officer |
1,628
-17.9%
0.20USD 318 |
1,628 -17.9% | 0.20 | USD 318 | |
| 2023-03-30 | 2023-03-29 | S Sale |
See Remarks Officer |
1,932
-28.5%
0.17USD 321 |
1,932 -28.5% | 0.17 | USD 321 | |
| 2023-03-30 | 2023-03-29 | S Sale |
See Remarks Officer |
5,373
-44.2%
0.17USD 887 |
5,373 -44.2% | 0.17 | USD 887 | |
| 2023-03-30 | 2023-03-29 | S Sale |
Chief Scientific Officer Officer |
11,762
-100.0%
0.17USD 1,943 |
11,762 -100.0% | 0.17 | USD 1,943 | |
| 2023-03-30 | 2023-03-28 | S Sale |
Chief Financial Officer Officer |
13,412
-100.0%
0.17USD 2,271 |
13,412 -100.0% | 0.17 | USD 2,271 | |
| 2023-03-30 | 2023-03-28 | S Sale |
Chief Technology Officer Officer |
1,932
-100.0%
0.20USD 386 |
1,932 -100.0% | 0.20 | USD 386 | |
| 2023-03-30 | 2023-03-28 | PS Planned sale |
Chief Technology Officer Officer |
7,432
-79.4%
0.20USD 1,487 |
7,432 -79.4% | 0.20 | USD 1,487 | |
| 2023-03-30 | 2023-03-28 | S Sale |
President & CEO Executive Director |
41,667
-84.5%
0.18USD 7,500 |
41,667 -84.5% | 0.18 | USD 7,500 | |
| 2023-02-21 | 2023-02-17 | S Sale |
Chief Financial Officer Officer |
2,570
-16.1%
0.59USD 1,522 |
2,570 -16.1% | 0.59 | USD 1,522 | |
| 2023-02-21 | 2023-02-17 | S Sale |
President & CEO Executive Director |
7,681
-13.5%
0.59USD 4,549 |
7,681 -13.5% | 0.59 | USD 4,549 | |
| 2023-02-21 | 2023-02-17 | S Sale |
See Remarks Officer |
1,603
-15.0%
0.59USD 950 |
1,603 -15.0% | 0.59 | USD 950 | |
| 2023-02-21 | 2023-02-17 | S Sale |
See Remarks Officer |
1,274
-9.5%
0.59USD 755 |
1,274 -9.5% | 0.59 | USD 755 | |
| 2023-02-21 | 2023-02-17 | S Sale |
Chief Technology Officer Officer |
1,391
-15.8%
0.59USD 824 |
1,391 -15.8% | 0.59 | USD 824 | |
| 2023-02-21 | 2023-02-17 | S Sale |
Chief Scientific Officer Officer |
2,407
-17.0%
0.59USD 1,425 |
2,407 -17.0% | 0.59 | USD 1,425 | |
| 2023-01-23 | 2023-01-20 | S Sale |
See Remarks Executive Director |
5,075
-21.8%
0.58USD 2,918 |
5,075 -21.8% | 0.58 | USD 2,918 | |
| 2023-01-23 | 2023-01-20 | S Sale |
See Remarks Officer |
836
-9.3%
0.58USD 481 |
836 -9.3% | 0.58 | USD 481 | |
| 2023-01-23 | 2023-01-20 | S Sale |
Chief Scientific Officer Officer |
1,082
-38.2%
0.58USD 622 |
1,082 -38.2% | 0.58 | USD 622 | |
| 2023-01-23 | 2023-01-20 | S Sale |
Chief Financial Officer Officer |
1,880
-37.6%
0.58USD 1,081 |
1,880 -37.6% | 0.58 | USD 1,081 | |
| 2023-01-23 | 2023-01-20 | S Sale |
Chief Technology Officer Officer |
1,069
-38.2%
0.58USD 615 |
1,069 -38.2% | 0.58 | USD 615 | |
| 2023-01-23 | 2023-01-20 | S Sale |
See Remarks Officer |
1,512
-37.8%
0.58USD 870 |
1,512 -37.8% | 0.58 | USD 870 | |
| 2022-09-16 | 2022-09-15 | B Purchase |
Flagship Ventures Fund V General Partner LLC Large shareholder |
210,743
0.00USD 0 |
210,743 | 0.00 | USD 0 | |
| 2022-09-16 | 2022-09-15 | B Purchase |
Flagship Ventures Fund V General Partner LLC Large shareholder |
722,590
0.00USD 0 |
722,590 | 0.00 | USD 0 | |
| 2022-09-15 | 2022-09-13 | B Purchase | Large shareholder |
5,000,000
+129.7%
1.50USD 7,500,000 |
5,000,000 +129.7% | 1.50 | USD 7,500,000 | |
| 2022-09-15 | 2022-09-13 | B Purchase | Non-Executive Director |
5,000,000
0.00USD 0 |
5,000,000 | 0.00 | USD 0 | |
| 2023-02-21 | 2022-08-17 | S Sale |
Chief Financial Officer Officer |
2,364
-22.0%
2.21USD 5,231 |
2,364 -22.0% | 2.21 | USD 5,231 | |
| 2023-02-21 | 2022-08-17 | S Sale |
President & CEO Executive Director |
7,112
-17.3%
2.21USD 15,739 |
7,112 -17.3% | 2.21 | USD 15,739 | |
| 2023-02-21 | 2022-08-17 | S Sale |
See Remarks Officer |
1,512
-20.6%
2.21USD 3,347 |
1,512 -20.6% | 2.21 | USD 3,347 | |
| 2023-02-21 | 2022-08-17 | S Sale |
See Remarks Officer |
984
-8.7%
2.21USD 2,177 |
984 -8.7% | 2.21 | USD 2,177 | |
| 2023-02-21 | 2022-08-17 | S Sale |
Chief Technology Officer Officer |
1,308
-22.1%
2.21USD 2,894 |
1,308 -22.1% | 2.21 | USD 2,894 | |
| 2023-02-21 | 2022-08-17 | S Sale |
Chief Scientific Officer Officer |
2,283
-25.1%
2.21USD 5,051 |
2,283 -25.1% | 2.21 | USD 5,051 | |
| 2022-02-07 | 2022-01-20 | B Purchase |
See Remarks Officer |
6,781
+inf%
7.37USD 49,978 |
6,781 +inf% | 7.37 | USD 49,978 | |
| 2021-09-28 | 2021-08-09 | PS Planned sale |
Chief Scientific Officer Officer |
549
-100.0%
21.79USD 11,962 |
549 -100.0% | 21.79 | USD 11,962 | |
| 2021-09-28 | 2021-08-09 | PS Planned sale |
Chief Scientific Officer Officer |
751
-57.8%
21.31USD 16,003 |
751 -57.8% | 21.31 | USD 16,003 | |
| 2021-09-28 | 2021-08-06 | PS Planned sale |
Chief Scientific Officer Officer |
1,300
-100.0%
20.16USD 26,206 |
1,300 -100.0% | 20.16 | USD 26,206 | |
| 2021-09-28 | 2021-06-08 | PS Planned sale |
See Remarks Officer |
1,640
-100.0%
26.06USD 42,740 |
1,640 -100.0% | 26.06 | USD 42,740 | |
| 2021-09-28 | 2021-06-08 | PS Planned sale |
See Remarks Officer |
6,893
-80.8%
25.57USD 176,276 |
6,893 -80.8% | 25.57 | USD 176,276 | |
| 2021-09-28 | 2021-06-08 | PS Planned sale |
Chief Technology Officer Officer |
1,004
-100.0%
26.04USD 26,146 |
1,004 -100.0% | 26.04 | USD 26,146 | |
| 2021-09-28 | 2021-06-08 | PS Planned sale |
Chief Technology Officer Officer |
6,272
-86.2%
25.53USD 160,130 |
6,272 -86.2% | 25.53 | USD 160,130 | |
| 2021-02-17 | 2021-02-17 | B Purchase | Non-Executive Director |
4,761
+inf%
21.00USD 99,981 |
4,761 +inf% | 21.00 | USD 99,981 | |
| 2020-10-23 | 2020-10-16 | B Purchase | Large shareholder |
235,000
+5.5%
15.00USD 3,525,000 |
235,000 +5.5% | 15.00 | USD 3,525,000 | |
| 2020-10-20 | 2020-10-16 | B Purchase | Non-Executive Director |
235,000
+10.4%
15.00USD 3,525,000 |
235,000 +10.4% | 15.00 | USD 3,525,000 | |
| 2020-10-20 | 2020-10-16 | B Purchase | Large shareholder |
235,000
+10.4%
15.00USD 3,525,000 |
235,000 +10.4% | 15.00 | USD 3,525,000 | |
| 2020-10-20 | 2020-10-16 | B Purchase |
Flagship Ventures Fund V General Partner LLC Large shareholder |
165,000
+16.9%
15.00USD 2,475,000 |
165,000 +16.9% | 15.00 | USD 2,475,000 | |
| 2021-04-30 | 2020-10-13 | B Purchase | Non-Executive Director |
6,600
+inf%
15.00USD 99,000 |
6,600 +inf% | 15.00 | USD 99,000 |